Adam M Veness
General Counsel at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 3,217616 held (−84%) | $110.61 | $356K | -25.5% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 616 | $111.18 | $68K | -25.9% |
| Aug 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 16,167 | $110.38 | $1.8M | -25.4% |
| Jun 18SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 16,77113,229 held (−56%) | $80.34 | $1.3M | +2.5% |
| Jun 18SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 13,229 | $81.38 | $1.1M | +1.2% |
- Sell
General Counsel Adam M Veness sold $356K of DNTH at $110.61 — cuts the stake by 84%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Adam M Veness sold $68K of DNTH at $111.18 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Adam M Veness sold $1.8M of DNTH at $110.38 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Adam M Veness sold $1.3M of DNTH at $80.34 — cuts the stake by 56%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Adam M Veness sold $1.1M of DNTH at $81.38 — pre-scheduled 10b5-1 plan sale.